IL6 and COVID-19: An IL-6 inhibitor used for moderate to severe active rheumatoid arthritis that is not responding to other therapies.Proposed to reduce the cytokine storm in COVID-19.Adverse effects: elevation of liver enzymes and an increased risk of reactivation of other respiratory infections.